Skip to content

Drug interactions

Bosentan + Pexidartinib

Severity: Major

Bosentan and Pexidartinib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pexidartinib is metabolized by CYP3A4, and inducers may reduce its exposure and effect. Both drugs are also hepatotoxic, so combined use adds liver risk.

What this interaction means in plain words

Bosentan and Pexidartinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Bosentan belongs to Miscellaneous; Pexidartinib belongs to Oncology.

Evidence level: Low

Why it happens

Bosentan induces CYP3A4, increasing pexidartinib clearance, and both drugs carry hepatotoxic potential.

What to do

Avoid concurrent use where possible. If used together, monitor liver tests and clinical response.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Bosentan and Pexidartinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Bosentan with Pexidartinib?

MediHelp rates the interaction as major. Bosentan and Pexidartinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Pexidartinib is metabolized by CYP3A4, and inducers may reduce its exposure and effect. Both drugs are also hepatotoxic, so combined use adds liver risk.

How serious is the interaction between Bosentan and Pexidartinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use where possible. If used together, monitor liver tests and clinical response.

What other medicines interact with Bosentan?

MediHelp also lists interactions of Bosentan with, for example, Cyclosporin, Glibenclamide, Glyburide-metformin. The full list is on the Bosentan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in